Search - tctmd.com

Displaying 941 - 957 of 957

Sort: Relevancy | Date

News Daily News

Apixaban Prevents Stroke in A-fib Patients Irrespective of Previous Stroke/TIA

L.A. McKeown

March 12, 2012

News Daily News

Meta-Analysis: Adjunctive Cilostazol Lowers Repeat Revascularization After PCI

Caitlin E. Cox

March 07, 2012

News Daily News

Meta-Análisis: Cilostazol Adyuvante Reduce la Necesidad de Volver a Revascularizar tras una PCI

Caitlin E. Cox

March 07, 2012

News Daily News

Nuevo Análisis PLATO: Las dosis de Aspirina podrían Explicar los Resultados Discordantes de Norteamérica

Caitlin E. Cox

March 06, 2012

News Daily News

New PLATO Analysis: Aspirin Dose May Explain Discordant North American Outcomes

Caitlin E. Cox

March 06, 2012

Presentation ISET 2012

The Value of Dual Antiplatelet Therapy During and After Endovascular Procedures: Results of a Randomized Trial - The MIRROR Study

Presenter: Gunnar Tepe

January 17, 2012

News Daily News

Six Months Sufficient for Dual Antiplatelet Therapy

Jason Kahn

October 17, 2011

News Conference News

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

August 31, 2011

News Conference News

Long-term Antiplatelet Therapy: All Risk, No Benefit

August 30, 2011

News Daily News

Prior Medication Adherence Predicts Post-PCI Clopidogrel Compliance

July 20, 2011

News Daily News

Adding Omega-3 Fatty Acids to Dual Antiplatelet Therapy May Reduce Thrombotic Risk

Leah Lawrence

May 26, 2011

News Daily News

Since COURAGE, Little Change in Optimal Medical Therapy for Stable PCI Patients

Caitlin E. Cox

May 10, 2011

News Conference News

EXCELLENT Outcomes Regardless of Antiplatelet Therapy Duration After DES

Caitlin E. Cox

April 05, 2011

News Daily News

Cilostazol Reduces Repeat Revascularizations for Long Lesions

March 06, 2011

News Daily News

New Anticoagulant More Effective Than Aspirin at Stroke Prevention in A-fib

Jason Kahn

February 09, 2011

News Daily News

CILON-T Published: Cilostazol Reduces Platelet Reactivity, Not Events

January 09, 2011

Advertisement

Apixaban Prevents Stroke in A-fib Patients Irrespective of Previous Stroke/TIA

Meta-Analysis: Adjunctive Cilostazol Lowers Repeat Revascularization After PCI

Meta-Análisis: Cilostazol Adyuvante Reduce la Necesidad de Volver a Revascularizar tras una PCI

Nuevo Análisis PLATO: Las dosis de Aspirina podrían Explicar los Resultados Discordantes de Norteamérica

New PLATO Analysis: Aspirin Dose May Explain Discordant North American Outcomes

The Value of Dual Antiplatelet Therapy During and After Endovascular Procedures: Results of a Randomized Trial - The MIRROR Study

Six Months Sufficient for Dual Antiplatelet Therapy

RUBY-1: Yet Another Novel Anticoagulant Tested in ACS Patients on Antiplatelets

Long-term Antiplatelet Therapy: All Risk, No Benefit

Prior Medication Adherence Predicts Post-PCI Clopidogrel Compliance

Adding Omega-3 Fatty Acids to Dual Antiplatelet Therapy May Reduce Thrombotic Risk

Since COURAGE, Little Change in Optimal Medical Therapy for Stable PCI Patients

EXCELLENT Outcomes Regardless of Antiplatelet Therapy Duration After DES

Cilostazol Reduces Repeat Revascularizations for Long Lesions

New Anticoagulant More Effective Than Aspirin at Stroke Prevention in A-fib

CILON-T Published: Cilostazol Reduces Platelet Reactivity, Not Events

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content